---
title: "Contract for the manufacture of Lateral Flow Antigen tests for Sars-Covid-2"
ocid: "ocds-h6vhtk-029cf6"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029cf6"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-029cf6.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-029cf6.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "DEPARTMENT OF HEALTH AND SOCIAL CARE"
published: "2021-03-18"
---

# Contract for the manufacture of Lateral Flow Antigen tests for Sars-Covid-2

Buyer: DEPARTMENT OF HEALTH AND SOCIAL CARE  
Current stage: Award  
OCID: ocds-h6vhtk-029cf6

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029cf6)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-029cf6.json)

## Summary

The Department of Health and Social Care is seeking proposals for the contract titled "Contract for the manufacture of Lateral Flow Antigen tests for Sars-Covid-2" located in the United Kingdom. This procurement falls under the goods category, specifically classified as diagnostic kits. This procurement method is characterised as a limited tender process, initiated due to extreme urgency stemming from the COVID-19 pandemic. The estimated initial value of the contract is £50,000,000, and the contract has been awarded to Global Access Diagnostics Ltd, with a total value of £1,152,000,000. The contract was signed on 16 February 2021 and addresses the urgent need for increased testing capacity in the UK.

This contracting opportunity presents significant business growth potential for companies within the diagnostics and medical equipment manufacturing sectors. Businesses with expertise in rapid test production, particularly for infectious diseases, will find this tender relevant. The urgent nature of this procurement indicates that suppliers who can ensure rapid delivery and scalability of manufacturing processes would be best suited to compete. Given the global competition in the lateral flow test market, companies are encouraged to leverage innovative manufacturing approaches and solid supply chain management to position themselves advantageously in response to such high-demand contracts.

## Notice

Manufacture of Lateral Flow Antigen tests for Sars-Covid-2 to respond to the urgent and growing need for more testing for the population of the UK

### Lot Information

Lot 1

Manufacture of Lateral Flow Antigen tests for Sars-Covid-2 to respond to the urgent and growing need for more testing for the population of the UK

### Procurement Information

The Value of Contract (inc. any possible extensions, exc. VAT) stated in this Contract Award Notice is not a committed value for the contract. Volumes supplied via this contract are forecast quarterly. The stated Value of Contract (inc. any possible extensions, exc. VAT) is an estimate based on projected volumes in the event that all potential contract extensions are enacted.1. The COVID-19 outbreak is a Public Health Emergency of International Concern as declared by the World Health Organisation on 30 January 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 March 2020.2. A key element of ensuring an effective response to the pandemic is ensuring that there is adequate testing. Therefore, ensuring surge LFT capacity, including sufficient availability of Lateral Flow Tests, is critical. 3. Mass testing of the UK Population is a key step in bringing the Pandemic under control. (Lateral Flow Tests produce quicker results than the current PCR (Polymerase Chain Reaction) test, and do not require a lab processing step.) LFT tests have only recently become viable as a means of testing, with multiple tests being progressed through to certification and approval. This was unforeseen by the DHSC and outside its control.4. DHSC's market analysis data demonstrates that the global market for LFT is volatile and highly competitive. Global manufacturing capability is limited to circa 120m units per day. World demand often outstrips supply. DHSC requirement is driven by the progress of the pandemic (including emerging variants), the changing efficacy of available LTF products and the severity of the second wave. That requirement means that the UK must make substantial purchases of tests.5. DHSC has been tasked with ensuring security of supply of a critical consumable asset (Lateral Flow Antigen tests) in a volatile and competitive global market place. This demand contract pursues that mandate by guaranteeing that DHSC is able to receive a stable supply of completed lateral flow test devices manufactured by a diagnostics tests manufacturing specialist, within the urgent timeframes required by the project. 6.A market engagement exercise for DHSC was carried out at pace due to the urgent requirement. Omega Diagnostics were identified via this process. 7. DHSC is satisfied the tests permitting use of the Negotiated procedure without prior publication (Regulation 32(2)(c)) are met:A. As far as is strictly necessary: The surge LFT capacity was identified as strictly necessary to meet the demand to scale up the testing programme in the UK.B. There are genuine reasons for extreme urgency: It is responding to COVID-19 immediately because of public health risks presenting a genuine emergency.C. The events that have led to the need for extreme urgency were unforeseeable: The Commission itself confirmed: "The current coronavirus crisis presents an extreme and unforeseeable urgency - precisely for such a situation our European rules enable public buyers to buy within a matter of days, even hours, if necessary." (Commissioner Breton, Internal Market, 01.04.2020).D. It is impossible to comply with the usual timescales in the PCR: It is not possible to comply with the timescales of another procedure due to the urgent requirement to ensure effective capacity.E. The situation is not attributable to the contracting authority - DHSC has not done anything to cause or contribute to the need for extreme urgency.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/005555-2021 |
| Notice type | Tender Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 18 Mar 2021 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 16 Feb 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1,152,000,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | DEPARTMENT OF HEALTH AND SOCIAL CARE |
| Locality | LONDON |
| Post town | South West London |
| Postcode | SW1H 0EU |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI3 Inner London - West |
| ITL 3 | TLI35 Westminster and City of London |
| Local authority | Westminster |
| Electoral ward | St James's |
| Westminster constituency | Cities of London and Westminster |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | GLOBAL ACCESS DIAGNOSTICS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33141625 - Diagnostic kits

## Release History

- 18 Mar 2021 at 17:06 - TenderUpdate - Tender Notice - https://www.find-tender.service.gov.uk/Notice/005555-2021
- 18 Mar 2021 at 13:16 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/005509-2021

## Notice URLs

- https://www.gov.uk/courts-tribunals
- https://www.gov.uk/government/organisations/department-of-health-and-social-care

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029cf6. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-029cf6.json.